A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

dc.authorid0000-0003-0466-0228
dc.authorid0000-0002-4823-2076
dc.authorid0000-0002-9076-2599
dc.authorid0000-0003-2575-6309
dc.authorid0000-0001-5637-8553
dc.authorid0000-0002-1663-015X
dc.contributor.authorGuliyeva, Vafa
dc.contributor.authorDemirkan, Fatma Gul
dc.contributor.authorYigit, Ramazan Emre
dc.contributor.authorEsen, Esra
dc.contributor.authorBayindir, Yagmur
dc.contributor.authorTorun, Ruya
dc.contributor.authorKilbas, Gulsah
dc.date.accessioned2025-05-10T19:38:42Z
dc.date.issued2024
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjectives We aimed to outline the demographic data, clinical spectrum, and treatment approach of sarcoidosis in a large group of patients and sought to figure out the variations of early-onset (EOS) and late-onset paediatric sarcoidosis (LOS). Methods The study followed a retrospective-descriptive design, with the analysis of medical records of cases diagnosed as paediatric sarcoidosis. Results Fifty-two patients were included in the study. The median age at disease onset and follow-up duration were 83 (28.2-119) and 24 (6-48) months, respectively. Ten (19.2%) cases had EOS (before 5th birthday) and 42 (80.7%) cases had LOS. The most common clinical findings at the time of the disease onset were ocular symptoms (40.4%) followed by joint manifestation (25%), dermatological symptoms (13.5%), and features related to multi-organ involvement (11.5%). Anterior uveitis was the most common (55%) one among ocular manifestations. Patients with EOS displayed joint, eye, and dermatological findings more commonly than patients with LOS. The recurrence rate of disease in patients with EOS (5.7%) and LOS (21.1%) were not statistically different (P = .7). Conclusions Patients with EOS and LOS may present with variable clinical features and studies addressing paediatric sarcoidosis cases in collaboration between disciplines will enhance the awareness of this rare disease among physicians and assist early diagnosis with lesser complications.
dc.identifier.doi10.1093/mr/road050
dc.identifier.endpage645
dc.identifier.issn1439-7595
dc.identifier.issn1439-7609
dc.identifier.issue3
dc.identifier.pmid37243724
dc.identifier.scopus2-s2.0-85179390713
dc.identifier.scopusqualityQ2
dc.identifier.startpage639
dc.identifier.urihttps://doi.org/10.1093/mr/road050
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9448
dc.identifier.volume34
dc.identifier.wosWOS:001002130700001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofModern Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectSarcoidosis
dc.subjectchildren
dc.subjectgranulomatous disease
dc.titleA clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9448
Boyut:
967.67 KB
Biçim:
Adobe Portable Document Format